Sandon Capital Investments Limited (AU:SNC) has released an update.
Sandon Capital Investments Limited reported a robust 5.2% gain in October, significantly outperforming the All Ordinaries Accumulation Index, which fell by 1.3%. Key contributors to this performance included companies like Nuix Ltd and Fleetwood Ltd, while Fleetwood Ltd secured a major contract expected to bolster its earnings. Additionally, IDT Australia saw a surge in revenue, driven by strong demand in its Advanced Therapies division, highlighting Sandon Capital’s strategic investments.
For further insights into AU:SNC stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Paramount Global (NASDAQ:PARA) Adds an Ad-Supported Tier in Europe
- How Ford (NYSE:F) Looks to Solve Its Hydrogen Engine Problem
- The Intel (NASDAQ:INTC) “Coffee Debacle” Is Now Solved
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
